Neugebauer WA - Search Results

1

Positional Scanning Identifies the Molecular Determinants of a High Affinity Multi-Leucine Inhibitor for Furin and PACE4.

Małuch I, Levesque C, Kwiatkowska A, Couture F, Ly K, Desjardins R, Neugebauer WA, Prahl A, Day R. Małuch I, et al. Among authors: neugebauer wa. J Med Chem. 2017 Apr 13;60(7):2732-2744. doi: 10.1021/acs.jmedchem.6b01499. Epub 2017 Mar 24. J Med Chem. 2017. PMID: 28287731

2

PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation.

Levesque C, Couture F, Kwiatkowska A, Desjardins R, Guérin B, Neugebauer WA, Day R. Levesque C, et al. Among authors: neugebauer wa. Oncotarget. 2015 Feb 28;6(6):3680-93. doi: 10.18632/oncotarget.2918. Oncotarget. 2015. PMID: 25682874 Free PMC article.

3

The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells.

Levesque C, Fugère M, Kwiatkowska A, Couture F, Desjardins R, Routhier S, Moussette P, Prahl A, Lammek B, Appel JR, Houghten RA, D'Anjou F, Dory YL, Neugebauer W, Day R. Levesque C, et al. J Med Chem. 2012 Dec 13;55(23):10501-11. doi: 10.1021/jm3011178. Epub 2012 Nov 14. J Med Chem. 2012. PMID: 23126600 Free PMC article.

4

Design, synthesis, and structure-activity relationship studies of a potent PACE4 inhibitor.

Kwiatkowska A, Couture F, Levesque C, Ly K, Desjardins R, Beauchemin S, Prahl A, Lammek B, Neugebauer W, Dory YL, Day R. Kwiatkowska A, et al. J Med Chem. 2014 Jan 9;57(1):98-109. doi: 10.1021/jm401457n. Epub 2013 Dec 18. J Med Chem. 2014. PMID: 24350995

5

Novel Insights into Structure-Activity Relationships of N-Terminally Modified PACE4 Inhibitors.

Kwiatkowska A, Couture F, Levesque C, Ly K, Beauchemin S, Desjardins R, Neugebauer W, Dory YL, Day R. Kwiatkowska A, et al. ChemMedChem. 2016 Feb 4;11(3):289-301. doi: 10.1002/cmdc.201500532. Epub 2016 Jan 11. ChemMedChem. 2016. PMID: 26751825

6

C-terminal amidation on aryl hydrazine resin.

Neugebauer WA, Parent A, Yuan XW, Day R. Neugebauer WA, et al. Adv Exp Med Biol. 2009;611:371-2. doi: 10.1007/978-0-387-73657-0_164. Adv Exp Med Biol. 2009. PMID: 19400231 No abstract available.

7

Selective and potent furin inhibitors protect cells from anthrax without significant toxicity.

Remacle AG, Gawlik K, Golubkov VS, Cadwell GW, Liddington RC, Cieplak P, Millis SZ, Desjardins R, Routhier S, Yuan XW, Neugebauer WA, Day R, Strongin AY. Remacle AG, et al. Among authors: neugebauer wa. Int J Biochem Cell Biol. 2010 Jun;42(6):987-95. doi: 10.1016/j.biocel.2010.02.013. Epub 2010 Mar 1. Int J Biochem Cell Biol. 2010. PMID: 20197107 Free PMC article.

8

Preparation and biological activities of potential vasopressin photoaffinity labels.

Barbeau D, Guay S, Neugebauer W, Escher E. Barbeau D, et al. J Med Chem. 1992 Jan;35(1):151-7. doi: 10.1021/jm00079a020. J Med Chem. 1992. PMID: 1732523

9

Angiotensin analogues palmitoylated in positions 1 and 4.

Maletínská L, Neugebauer W, Pérodin J, Lefebvre M, Escher E. Maletínská L, et al. J Med Chem. 1997 Sep 26;40(20):3271-9. doi: 10.1021/jm9608669. J Med Chem. 1997. PMID: 9379447

10

New enzyme-activated solubility-switchable contrast agent for magnetic resonance imaging: from synthesis to in vivo imaging.

Jastrzebska B, Lebel R, Therriault H, McIntyre JO, Escher E, Guérin B, Paquette B, Neugebauer WA, Lepage M. Jastrzebska B, et al. Among authors: neugebauer wa. J Med Chem. 2009 Mar 26;52(6):1576-81. doi: 10.1021/jm801411h. J Med Chem. 2009. PMID: 19228016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page